BC-7013

Modify Date: 2024-01-27 11:04:40

BC-7013 Structure
BC-7013 structure
Common Name BC-7013
CAS Number 1028291-66-8 Molecular Weight 500.69
Density N/A Boiling Point N/A
Molecular Formula C29H40O5S Melting Point N/A
MSDS N/A Flash Point N/A

 Use of BC-7013


BC-7013 is a novel semi-synthetic pleuromutilin derivative. BC-7013 has excellent activity against Gram-positive pathogenic bacteria. BC-7013 exhibits potent antibacterial properties against both Staphylococcus, Streptococcus and penicillin-resistant Streptococcus pneumoniae. BC-7013 has activity against Gram-positive pathogenic bacteria, BC-7013 is useful in the research of acute bacterial skin and skin structure infection (ABSSSI)[1].

 Names

Name BC-7013

 BC-7013 Biological Activity

Description BC-7013 is a novel semi-synthetic pleuromutilin derivative. BC-7013 has excellent activity against Gram-positive pathogenic bacteria. BC-7013 exhibits potent antibacterial properties against both Staphylococcus, Streptococcus and penicillin-resistant Streptococcus pneumoniae. BC-7013 has activity against Gram-positive pathogenic bacteria, BC-7013 is useful in the research of acute bacterial skin and skin structure infection (ABSSSI)[1].
Related Catalog
Target

MIC50: 0.015µg/mL (303 tested S. aureus isolates)[2]

References

[1]. Shang R, et al. Efficient antibacterial agents: a review of the synthesis, biological evaluation and mechanism of pleuromutilin derivatives. Curr Top Med Chem. 2013;13(24):3013-25.  

[2]. Biedenbach D J, et al. In vitro antibacterial spectrum of BC-7013, a novel pleuromutilin derivative for topical use in humans. Interscience Conference on Antimicrobial Agents and Chemotherapy. 2009, 49: 199

 Chemical & Physical Properties

Molecular Formula C29H40O5S
Molecular Weight 500.69
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.